Viewing Study NCT02396966


Ignite Creation Date: 2025-12-24 @ 4:11 PM
Ignite Modification Date: 2026-04-21 @ 9:57 PM
Study NCT ID: NCT02396966
Status: COMPLETED
Last Update Posted: 2018-12-21
First Post: 2015-03-18
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Quality of Life (QoL) in Subjects With Acromegaly Under Lanreotide AutogelĀ® Treatment.
Sponsor: Ipsen
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: A-38-52030-306
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators